Reproducibility Studies:
Key Questions for IVD Manufacturers When Selecting a Lab Testing Partner
About this webinar
When in vitro diagnostic (IVD) manufacturers develop new assays on their instruments, they need to perform reproducibility studies, typically with a minimum of two external lab partners, in order to demonstrate the robustness and reliability of a test and to demonstrate that the test can be reliably performed by other laboratories using the same or similar equipment and methods.
Register for this webinar to learn the key capabilities IVD manufacturers should seek when choosing a trusted lab partner.
Who should attend
- In vitro diagnostic (IVD) manufacturers involved in assay development
- Laboratory managers and directors
- Research and development scientists
- Biomedical scientists and researchers working with IVD assays
- Quality assurance and quality control professionals
- Testing and validation professionals
- Professionals involved in clinical laboratory testing and accreditation
- Medical Device Manufacturers
What you will learn
This webinar will identify the four most important questions to take into consideration when selecting potential lab partners, and why they matter.
Featured Speakers
Greg Baschkopf
Greg Baschkopf serves as Sr. Director of IVD Services and Innovation at Quest Diagnostics. He has more than 15 years of experience in the molecular diagnostic lab industry. His career began in the lab, and he has held positions in sales, training, and product management. Greg is a graduate of Boston University where he received a BA in Biology.
Neelam Dhiman, PhD
Clinical Associate Professor, Department of Pathology and Laboratory Medicine, Texas A&M University
Dr Dhiman has 24 years of clinical research experience in the immunogenetics of vaccines, including a clinical microbiology fellowship at Mayo Clinic in Rochester, MN. She is a scientific expert in molecular infectious disease and women’s health, and is actively engaged in multiple clinical trials with a special interest in rapid molecular diagnostics for sepsis. Dr Dhiman is widely published, serves as a scientific reviewer for multiple internal scientific journals, and has presented at a variety of national and international conferences.
Partner for this event
Quest Diagnostics
Connecting life sciences to Quest Diagnostics
Access the reach, expertise, and renowned quality of Quest for every milestone of your project—from R&D consulting through clinical trials, commercialization, and post-launch surveillance. Together we have the power to deliver better outcomes.